Microbiology

  1. Identification of SARS-CoV2-mediated suppression of NRF2 signaling reveals a potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate

    1. David Olagnier
    2. Ensieh Farahani
    3. Jacob Thyrsted
    4. Julia B. Cadanet
    5. Angela Herengt
    6. Manja Idorn
    7. Alon Hait
    8. Bruno Hernaez
    9. Alice Knudsen
    10. Marie Beck Iversen
    11. Mirjam Schilling
    12. Sofie E. Jørgensen
    13. Michelle Thomsen
    14. Line Reinert
    15. Michael Lappe
    16. Huy-Dung Hoang
    17. Victoria H. Gilchrist
    18. Anne Louise Hansen
    19. Rasmus Ottosen
    20. Camilla Gunderstofte
    21. Charlotte Møller
    22. Demi van der Horst
    23. Suraj Peri
    24. Siddarth Balachandran
    25. Jinrong Huang
    26. Martin Jakobsen
    27. Esben B. Svenningsen
    28. Thomas B. Poulsen
    29. Lydia Bartsch
    30. Anne L. Thielke
    31. Yonglun Luo
    32. Tommy Alain
    33. Jan Rehwinkel
    34. Antonio Alcamí
    35. John Hiscott
    36. Trine Mogensen
    37. Søren R. Paludan
    38. Christian K. Holm

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain

    1. Nicholas C. Wu
    2. Meng Yuan
    3. Hejun Liu
    4. Chang-Chun D. Lee
    5. Xueyong Zhu
    6. Sandhya Bangaru
    7. Jonathan L. Torres
    8. Tom G. Caniels
    9. Philip J.M. Brouwer
    10. Marit J. van Gils
    11. Rogier W. Sanders
    12. Andrew B. Ward
    13. Ian A. Wilson

    Reviewed by ScreenIT

    3 evaluationsAppears in 1 listLatest version Latest activity

  3. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro

    1. Jeremy R.A. Paull
    2. Graham P. Heery
    3. Michael D. Bobardt
    4. Alex Castellarnau
    5. Carolyn A. Luscombe
    6. Jacinth K. Fairley
    7. Philippe A. Gallay

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    3 evaluationsAppears in 2 listsLatest version Latest activity

  4. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways

    1. Manon Laporte
    2. Annelies Stevaert
    3. Valerie Raeymaekers
    4. Ria Van Berwaer
    5. Katleen Martens
    6. Stefan Pöhlmann
    7. Lieve Naesens

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Spike protein disulfide disruption as a potential treatment for SARS-CoV-2

    1. Andrey M. Grishin
    2. Nataliya V. Dolgova
    3. Shelby Harms
    4. Ingrid J. Pickering
    5. Graham N. George
    6. Darryl Falzarano
    7. Miroslaw Cygler

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Rapid host response to an infection with Coronavirus. Study of transcriptional responses with Porcine Epidemic Diarrhea Virus

    1. Wei Hou
    2. Fei Liu
    3. Wim H.M. van der Poel
    4. Marcel M. Hulst

    Reviewed by ScreenIT

    3 evaluationsAppears in 1 listLatest version Latest activity

  7. Nanodroplet-Benzalkonium Chloride Formulation Demonstrates In Vitro and Ex-Vivo Broad-Spectrum Antiviral Activity Against SARS-CoV-2 and other Enveloped Viruses

    1. Jessie Pannu
    2. Susan Ciotti
    3. Shyamala Ganesan
    4. George Arida
    5. Chad Costley
    6. Ali Fattom

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Looking for pathways related to COVID-19 phenotypes: Confirmation of pathogenic mechanisms by SARS-CoV-2 - Host interactome

    1. Francesco Messina
    2. Emanuela Giombini
    3. Chiara Montaldo
    4. Ashish Arunkumar Sharma
    5. Mauro Piacentini
    6. Antonio Zoccoli
    7. Rafick-Pierre Sekaly
    8. Franco Locatelli
    9. Alimuddin Zumla
    10. Markus Maeurer
    11. Maria R. Capobianchi
    12. Francesco Nicola Lauria
    13. Giuseppe Ippolito
    14. COVID 19 INMI Network Medicine for IDs Study Group.

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases

    1. M. Zeeshan Chaudhry
    2. Kathrin Eschke
    3. Markus Hoffmann
    4. Martina Grashoff
    5. Leila Abassi
    6. Yeonsu Kim
    7. Linda Brunotte
    8. Stephan Ludwig
    9. Andrea Kröger
    10. Frank Klawonn
    11. Stefan H. Pöhlmann
    12. Luka Cicin-Sain

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  10. Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase

    1. Mark Andrew White
    2. Wei Lin
    3. Xiaodong Cheng

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 188 of 252 Next